Comparing Imbruvica vs Rituxan
| Imbruvica | Rituxan |
|
|---|
| Imbruvica (ibrutinib) | Rituxan (rituximab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Imbruvica is an oral tablet that may be taken once daily to treat certain types of cancers in adults or to treat chronic Graft Versus Host disease in adults and children older than 1 year. It works... View more |
Prescription only
Rituxan is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid... View more |
Related suggestions Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma
Popular comparisons
|
|||||||||||||||
| More about Imbruvica (ibrutinib) | More about Rituxan (rituximab) | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Imbruvica has an average rating of 5.4 out of 10 from a total of 45 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 44% reported a negative effect. |
Rituxan has an average rating of 8.0 out of 10 from a total of 38 ratings on Drugs.com. 78% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
Common side effects include:
See also: Imbruvica side effects in more detail. |
See also: Rituxan side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Imbruvica prices |
View all Rituxan prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Other rituximab brands include: Riabni, Ruxience, Truxima | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
6 hours |
59.8 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 423 drugs are known to interact with Imbruvica:
|
A total of 155 drugs are known to interact with Rituxan:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
November 13, 2013 |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.